相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer
Thomas S. C. Ng et al.
RADIOLOGY (2021)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Daniel Ajona et al.
NATURE CANCER (2020)
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
Wantong Yao et al.
NATURE (2019)
randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.
Margaret A. Tempero et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges
Harshita et al.
NANOMEDICINE (2019)
EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis
Szu-Wei Lee et al.
DEVELOPMENTAL CELL (2019)
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Andrew M. Waters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
The Canonical Wnt Pathway Drives Macropinocytosis in Cancer
Gil Redelman-Sidi et al.
CANCER RESEARCH (2018)
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Lixin Wan et al.
MOLECULAR CELL (2018)
PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells
Seong M. Kim et al.
CANCER DISCOVERY (2018)
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Harnessing albumin as a carrier for cancer therapies
Ella N. Hoogenboezem et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin
Hye-Yeong Kim et al.
ACS NANO (2018)
Investigation on the Interaction of Dabrafenib with Human Serum Albumin Using Combined Experiment and Molecular Dynamics Simulation: Exploring the Binding Mechanism, Esterase-like Activity, and Antioxidant Activity
Zili Suo et al.
MOLECULAR PHARMACEUTICS (2018)
Site occupancy calibration of taxane pharmacology in live cells and tissues
Javier J. Pineda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types
Marie-Claire Wagle et al.
NPJ PRECISION ONCOLOGY (2018)
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
Shawn M. Davidson et al.
NATURE MEDICINE (2017)
Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts
Miles A. Miller et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging
Michael F. Cuccarese et al.
NATURE COMMUNICATIONS (2017)
Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
Jane Cullis et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials
Henry A. Havel
AAPS JOURNAL (2016)
SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
Manuel Hidalgo et al.
CLINICAL CANCER RESEARCH (2015)
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
Miles A. Miller et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Miles A. Miller et al.
NATURE COMMUNICATIONS (2015)
Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery
Jennica L. Zaro
AAPS JOURNAL (2015)
High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells
Sergi Regot et al.
CELL (2014)
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
Albrecht Neesse et al.
GUT (2014)
Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung Cancer
Corey J. Langer et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Fluorogenic probes for live-cell imaging of the cytoskeleton
Grazvydas Lukinavicius et al.
NATURE METHODS (2014)
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer
David G. McFadden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Next Generation of Orthotopic Thyroid Cancer Models: Immunocompetent Orthotopic Mouse Models of BRAFV600E-Positive Papillary and Anaplastic Thyroid Carcinoma
Pierre Vanden Borre et al.
THYROID (2014)
Combined BRAFV600E- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer
Pierre Vanden Borre et al.
ONCOTARGET (2014)
nab-Paclitaxel mechanisms of action and delivery
Denise A. Yardley
JOURNAL OF CONTROLLED RELEASE (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Multifunctional Albumin Nanoparticles As Combination Drug Carriers for Intra-Tumoral Chemotherapy
Mingjie Cui et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Carl D. Walkey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Shannon M. McAuliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Suppression of AMPK Activation via S485 Phosphorylation by IGF-I during Hyperglycemia Is Mediated by AKT Activation in Vascular Smooth Muscle Cells
Junyu Ning et al.
ENDOCRINOLOGY (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
18F Labeled Nanoparticles for in Vivo PET-CT Imaging
Neat K. Devaraj et al.
BIOCONJUGATE CHEMISTRY (2009)
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
M. A. Bush et al.
DIABETES OBESITY & METABOLISM (2009)
Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor
Mark J. Mulvihill et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
Michel DuPage et al.
NATURE PROTOCOLS (2009)
SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
Neil Desai et al.
TRANSLATIONAL ONCOLOGY (2009)
IGF-1 receptor signaling pathways and effects of AMPK activation on IGF-1-induced progesterone secretion in hen granulosa cells
Lucie Tosca et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2008)
CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway
Wen Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation
K. Langer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
The epidermal growth factor receptor pathway: A model for targeted therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2006)
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
E Menu et al.
BLOOD (2006)
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer
DM Dinulescu et al.
NATURE MEDICINE (2005)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
K Langer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
分享论文
